IL253889A0 - Detection of brain injury - Google Patents
Detection of brain injuryInfo
- Publication number
- IL253889A0 IL253889A0 IL253889A IL25388917A IL253889A0 IL 253889 A0 IL253889 A0 IL 253889A0 IL 253889 A IL253889 A IL 253889A IL 25388917 A IL25388917 A IL 25388917A IL 253889 A0 IL253889 A0 IL 253889A0
- Authority
- IL
- Israel
- Prior art keywords
- detection
- brain damage
- brain
- damage
- Prior art date
Links
- 230000006931 brain damage Effects 0.000 title 1
- 231100000874 brain damage Toxicity 0.000 title 1
- 208000029028 brain injury Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/669,454 US9605315B2 (en) | 2014-03-26 | 2015-03-26 | Detection of traumatic brain injury |
| PCT/US2015/051518 WO2016153549A1 (en) | 2015-03-26 | 2015-09-22 | Detection of brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL253889A0 true IL253889A0 (en) | 2017-10-31 |
Family
ID=56979279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL253889A IL253889A0 (en) | 2015-03-26 | 2017-08-07 | Detection of brain injury |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9605315B2 (enExample) |
| EP (1) | EP3274008B1 (enExample) |
| JP (1) | JP2018518147A (enExample) |
| CN (1) | CN107427614B (enExample) |
| AU (2) | AU2015387481B2 (enExample) |
| CA (1) | CA2976347A1 (enExample) |
| CL (1) | CL2017002420A1 (enExample) |
| ES (1) | ES3014311T3 (enExample) |
| IL (1) | IL253889A0 (enExample) |
| SG (1) | SG11201707332XA (enExample) |
| WO (1) | WO2016153549A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2833375A1 (en) | 2011-04-18 | 2012-10-26 | Diamir, Llc | Methods of using mirna from bodily fluids for early detection and monitoring of mild cognitive impairment (mci) and alzheimer's disease (ad) |
| CA2931082C (en) | 2013-11-18 | 2024-01-23 | Diamir, Llc | Methods of using mirnas from bodily fluids for detection and monitoring of parkinson's disease (pd) |
| EP3377074B1 (en) * | 2015-11-18 | 2024-01-03 | Dignity Health | Methods of diagnosing post traumatic epilepsy |
| US10975436B2 (en) | 2016-01-05 | 2021-04-13 | Diamir, Llc | Methods of using miRNA from bodily fluids for diagnosis and monitoring of neurodevelopmental disorders |
| GB201603967D0 (en) * | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| ES2993025T3 (en) | 2016-03-21 | 2024-12-20 | Diamir Llc | Methods of using mirnas from bodily fluids for detection and differentiation of neurodegenerative diseases |
| CN108300788B (zh) * | 2017-01-13 | 2021-07-09 | 中国人民解放军南京军区南京总医院 | 一种用于检测轻型脑外伤的微小核糖核酸组合及其应用 |
| EP3600472B1 (en) * | 2017-03-23 | 2024-04-17 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| US10781487B2 (en) | 2017-07-24 | 2020-09-22 | Diamir, Llc | miRNA-based methods for detecting and monitoring aging |
| CN119985995A (zh) | 2018-05-31 | 2025-05-13 | 阿米达斯公司 | 用于检测创伤性脑损伤的组合物和方法 |
| WO2025039033A1 (en) * | 2023-08-21 | 2025-02-27 | Glia Diagnostics Pty Ltd | Methods and reagents for diagnosis and/or prognosis of traumatic brain injury |
| CN118314963B (zh) * | 2023-11-13 | 2024-10-29 | 中国人民解放军空军特色医学中心 | 一种基于lasso回归的血小板储存损伤风险预测模型及其构建方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL145209A0 (en) * | 2000-09-06 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
| EP1549301A2 (en) * | 2002-06-10 | 2005-07-06 | Oklahoma Medical Research Foundation | A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| EP2271931A4 (en) * | 2008-04-25 | 2011-10-12 | Merck Sharp & Dohme | MICRO-RNA BIOMARKERS FOR TISSUE INJURIES |
| AU2010291933B2 (en) * | 2009-09-14 | 2016-09-08 | Banyan Biomarkers, Inc. | Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury |
| WO2011149354A1 (en) * | 2010-05-28 | 2011-12-01 | Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg | Mirnas involved in the blood brain barrier function |
| TW201231671A (en) * | 2011-01-28 | 2012-08-01 | Univ Kaohsiung Medical | Method and kit for in vitro diagnosis of atherosclerosis |
| WO2013032962A2 (en) | 2011-08-28 | 2013-03-07 | The Board Of Trustees Of The Leland Stanford Junior University | Micro rnas to treat stroke, ischemic brain injury, traumatic brain injury, and neurodegenerative disease |
| AU2012308092A1 (en) * | 2011-09-13 | 2014-04-17 | Commonwealth Scientific And Industrial Research Organisation | Detection of viral infection |
| AU2013219799C1 (en) * | 2012-02-15 | 2017-12-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of treating and preventing diseases and disorders of the central nervous system |
| US9101580B2 (en) * | 2012-12-18 | 2015-08-11 | Matthew Bennett | Compositions and methods for treating traumatic brain injury |
-
2015
- 2015-03-26 US US14/669,454 patent/US9605315B2/en active Active
- 2015-09-22 JP JP2017541658A patent/JP2018518147A/ja active Pending
- 2015-09-22 EP EP15886700.2A patent/EP3274008B1/en active Active
- 2015-09-22 CN CN201580077882.4A patent/CN107427614B/zh active Active
- 2015-09-22 SG SG11201707332XA patent/SG11201707332XA/en unknown
- 2015-09-22 WO PCT/US2015/051518 patent/WO2016153549A1/en not_active Ceased
- 2015-09-22 AU AU2015387481A patent/AU2015387481B2/en active Active
- 2015-09-22 CA CA2976347A patent/CA2976347A1/en active Pending
- 2015-09-22 ES ES15886700T patent/ES3014311T3/es active Active
-
2017
- 2017-02-14 US US15/432,172 patent/US10202649B2/en active Active
- 2017-08-07 IL IL253889A patent/IL253889A0/en unknown
- 2017-09-26 CL CL2017002420A patent/CL2017002420A1/es unknown
-
2018
- 2018-12-17 US US16/222,864 patent/US10815529B2/en active Active
-
2021
- 2021-10-29 AU AU2021258088A patent/AU2021258088B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10815529B2 (en) | 2020-10-27 |
| SG11201707332XA (en) | 2017-10-30 |
| US20170268058A1 (en) | 2017-09-21 |
| EP3274008C0 (en) | 2024-12-04 |
| AU2015387481A1 (en) | 2017-08-03 |
| ES3014311T3 (en) | 2025-04-21 |
| EP3274008A1 (en) | 2018-01-31 |
| JP2018518147A (ja) | 2018-07-12 |
| US20190352716A1 (en) | 2019-11-21 |
| AU2021258088B2 (en) | 2024-11-28 |
| CN107427614A (zh) | 2017-12-01 |
| EP3274008A4 (en) | 2018-10-24 |
| EP3274008B1 (en) | 2024-12-04 |
| US10202649B2 (en) | 2019-02-12 |
| WO2016153549A1 (en) | 2016-09-29 |
| US9605315B2 (en) | 2017-03-28 |
| CN107427614B (zh) | 2021-10-15 |
| AU2021258088A1 (en) | 2021-11-25 |
| CL2017002420A1 (es) | 2018-07-13 |
| AU2015387481B2 (en) | 2021-08-05 |
| US20150344954A1 (en) | 2015-12-03 |
| CA2976347A1 (en) | 2016-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255364A0 (en) | Malware warning | |
| EP3564866A4 (en) | CALCULATION PROCESS | |
| EP3397334A4 (en) | GANGLION-AORTICORENALE DETECTION | |
| IL253889A0 (en) | Detection of brain injury | |
| EP3408402A4 (en) | MAGNETIC ELECTROCHEMICAL DETECTION | |
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| PL3167096T3 (pl) | Dwuetapowy sposób nanoszenia | |
| DK3132009T3 (da) | Fremgangsmåde | |
| PL3457851T3 (pl) | Pochodne sobetiromu | |
| DK3283210T3 (da) | Fremgangsmåde | |
| EP3398042A4 (en) | REMOVAL OF BACKGROUND | |
| HUE042606T2 (hu) | Eljárás apolipoprotein kimutatására | |
| FR3023290B1 (fr) | Derives de flavaglines | |
| FI20145128L (fi) | Varhainen akuutin kaatumisriskin havaitseminen | |
| IL254502B (en) | Solid forms of menaquinols | |
| EP3498837A4 (en) | Genome editing method | |
| EP3384016A4 (en) | MANIPULATED PHAGEMIDES | |
| IL248608A0 (en) | Heparan sulphates | |
| FR3024647B1 (fr) | Transat de puericulture | |
| LT3253772T (lt) | Diosmino ruošimo būdas | |
| DK3285588T3 (da) | Fremgangsmåde | |
| EP3341707A4 (en) | SUBSTANCE DETECTION | |
| PL3350308T3 (pl) | Zastosowanie włókna liocelowego | |
| DK3551916T3 (da) | Detekteringsfremgangsmåde | |
| LT3183264T (lt) | Pegilinimo būdas |